We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$44.9B
AUM Growth
+$4.18B
Cap. Flow
+$1.17B
Cap. Flow %
2.6%
Top 10 Hldgs %
17.28%
Holding
2,386
New
190
Increased
819
Reduced
1,044
Closed
185

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$237M
2
PFE icon
Pfizer
PFE
+$231M
3
AMGN icon
Amgen
AMGN
+$181M
4
CSCO icon
Cisco
CSCO
+$179M
5
NBIS
Nebius Group N.V.
NBIS
+$159M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$288M
2
UPS icon
United Parcel Service
UPS
+$251M
3
KO icon
Coca-Cola
KO
+$134M
4
T icon
AT&T
T
+$111M
5
VEEV icon
Veeva Systems
VEEV
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 18.78%
2 Technology 15.44%
3 Financials 11.36%
4 Consumer Discretionary 10.6%
5 Communication Services 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDN icon
2101
Intellicheck
IDN
$49.2M
$1K ﹤0.01%
+79
New +$490
INFU icon
2102
InfuSystem Holdings
INFU
$244M
$1K ﹤0.01%
159
JILL icon
2103
J. Jill
JILL
$351M
$1K ﹤0.01%
60
+1
+2% +$8
KN icon
2104
Knowles
KN
$2.97B
$1K ﹤0.01%
+13
New +$279
KZR
2105
DELISTED
Kezar Life Sciences
KZR
$1K ﹤0.01%
16
LAKE icon
2106
Lakeland Industries
LAKE
$104M
$1K ﹤0.01%
+23
New +$247
LARK icon
2107
Landmark Bancorp
LARK
$203M
$1K ﹤0.01%
48
-15
-24% -$258
LCTX icon
2108
Lineage Cell Therapeutics
LCTX
$268M
$1K ﹤0.01%
+20
New +$17
LEE icon
2109
Lee Enterprises
LEE
$165M
$1K ﹤0.01%
22
LEU icon
2110
Centrus Energy
LEU
$2.91B
$1K ﹤0.01%
+30
New +$169
LFVN icon
2111
LifeVantage
LFVN
$77.4M
$1K ﹤0.01%
+20
New +$294
LPCN icon
2112
Lipocine
LPCN
$18.1M
$1K ﹤0.01%
5
-3
-38% -$77
LRMR icon
2113
Larimar Therapeutics
LRMR
$406M
$1K ﹤0.01%
4
LTC
2114
LTC Properties
LTC
$2.34B
$1K ﹤0.01%
15
+14
+1,400% +$673
LVO icon
2115
LiveOne
LVO
$49.4M
$1K ﹤0.01%
+2
New +$34
MCB icon
2116
Metropolitan Bank Holding Corp
MCB
$1.12B
$1K ﹤0.01%
24
MCS icon
2117
Marcus Corp
MCS
$843M
$1K ﹤0.01%
+40
New +$1.35K
MLAB icon
2118
Mesa Laboratories
MLAB
$712M
$1K ﹤0.01%
+3
New +$703
MPAA icon
2119
Motorcar Parts of America
MPAA
$204M
$1K ﹤0.01%
+26
New +$503
MRSN
2120
DELISTED
Mersana Therapeutics
MRSN
-2
Closed -$146
NGVC icon
2121
Vitamin Cottage Natural Grocers
NGVC
$665M
$1K ﹤0.01%
32
+3
+10% +$28
NINE
2122
DELISTED
Nine Energy Service
NINE
$1K ﹤0.01%
23
-6,623
-100% -$38.5K
OPRX icon
2123
OptimizeRx
OPRX
$142M
$1K ﹤0.01%
2
-130
-98% -$1.47K
OSUR icon
2124
OraSure Technologies
OSUR
$239M
$1K ﹤0.01%
94
-5
-5% -$40
OVID icon
2125
Ovid Therapeutics
OVID
$529M
$1K ﹤0.01%
+320
New +$1.01K

Similar funds

Federated Hermes's Q4 2019 Portfolio in Review

As of Q4 2019, Federated Hermes held 2,386 positions worth $44.9B, up 10% from $40.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Federated Hermes's Q4 2019 filing shows 190 new, 819 increased, 1,044 reduced and 185 closed positions. Its largest new stake was Nebius Group N.V.: 4,250,752 shares worth $185M. The largest sale was PepsiCo, an estimated $288M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Federated Hermes's largest Q4 2019 buy was Nebius Group N.V.: 4,250,752 shares worth $185M.
  • Federated Hermes added most to Alibaba in Q4 2019, an estimated $237M increase.
  • Federated Hermes's biggest Q4 2019 reduction was PepsiCo, cutting an estimated $288M.
  • Federated Hermes fully exited Trip.com Group in Q4 2019, selling an estimated $79.8M.
  • Federated Hermes's ten largest holdings make up 17% of its $44.9B portfolio in Q4 2019.
  • Federated Hermes opened 190 new positions and closed 185 in Q4 2019.
  • Federated Hermes's portfolio value rose 10% quarter-over-quarter to $44.9B.

Based on Federated Hermes's 13F filing for Q4 2019, filed 14 Feb 2020.